(0.02%) 5 470.52 points
(0.00%) 39 111 points
(0.32%) 17 775 points
(-0.48%) $80.44
(-4.50%) $2.63
(-0.85%) $2 311.00
(0.01%) $28.87
(2.29%) $1 009.00
(0.27%) $0.936
(0.65%) $10.67
(0.46%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. It offers SAB-142 anti-thymocyte globulin for Type 1 diabetes; SAB-176 for seasonal influenza; and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-COV)...
Stats | |
---|---|
Today's Volume | 49 104 |
Average Volume | 0 |
Market Cap | 23.93M |
EPS | $-0.540 ( Q1 | 2024-05-20 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0.120 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-07 | Sullivan Eddie Joe | Buy | 1 740 | Common Stock |
2023-11-30 | King Michael | Buy | 5 000 | Common Stock |
2023-11-29 | Reich Samuel J | Buy | 11 000 | Common Stock |
2023-11-24 | Sessa Capital (master), L.p. | Buy | 4 584 571 | Common Stock |
2023-11-24 | Sessa Capital (master), L.p. | Buy | 28 380 | Series A-2 Convertible Preferred Stock |
INSIDER POWER |
---|
67.59 |
Last 48 transactions |
Buy: 15 469 696 | Sell: 3 137 380 |
SAB Biotherapeutics, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
SAB Biotherapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $2.24M |
Gross Profit: | $-1.51M (-67.28 %) |
EPS: | $-7.64 |
FY | 2023 |
Revenue: | $2.24M |
Gross Profit: | $-1.51M (-67.28 %) |
EPS: | $-7.64 |
FY | 2022 |
Revenue: | $23.90M |
Gross Profit: | $20.61M (86.23 %) |
EPS: | $-4.31 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. It offers SAB-142 anti-thymocyte globulin for Type 1 diabetes; SAB-176 for seasonal influenza; and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-COV). SAB Biotherapeutics, Inc. was incorporated in 2014 and is based in Sioux Falls, South Dakota with an additional office in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators